PANS and PANDAS – A step forward?
Proposed criteria for documenting GAS infection in PANS pediatric patients
- A rise in serial antibody level, regardless of rapid test or culture result. This definition does not require clinical pharyngitis.
- Acute pharyngitis with a positive GAS throat culture, with or without a rising antibody level.
- Pharyngitis with characteristic palatal petechiae.
- Pharyngitis with a characteristic scarlatiniform rash.
- Pharyngitis without a throat swab or serology, but intimate (usually household) exposure to a proven GAS case.
- Asymptomatic pharyngeal colonization documented after an intimate exposure.
- Asymptomatic pharyngeal colonization after a negative throat swab documented within the prior 3-4 months.
- Single ASO or ADB antibody level within 6 months after the initial onset of neuropsychiatric symptoms may be accepted as positive if it is more than 95th percentile, using the laboratory’s normal standard for children of comparable age, or provisionally ASO greater than or equal to 1:480 or ADB greater than or equal to 1:1280.
- Both ASO and ADB are elevated at more than 80% percentile for age in the same serum sample within 6 months after the initial onset of neuropsychiatric symptoms.
- Culture-documented streptococcal dermatitis.
Source: J Child Adolesc Psychopharmacol. 2017. doi: 10.1089/cap.2016.0151.
Dr. Pelton is chief of pediatric infectious disease and coordinator of the maternal-child HIV program at Boston Medical Center. Dr. Pelton said he had no relevant financial disclosures. Email him at pdnews@frontlinemedcom.com.